Blog Post
Sister
7 years agoMember
@Giovanna_BCNA To be honest, much as I was interested, I was so bemused by the sheer number of names of drugs, etc being spoken about that I completely lost the thread very early on - so much so that I didn't continue. I am an educated (although not in the Science field), reasonably intelligent person with an interest in the subject and it completely lost me. I did try to follow with the slides but they were also rather dense and difficult to tie in with the presentation.
Related Content
The Pharmaceutical Benefits Advisory Committee (PBAC) has recommended the drug Enhertu (trastuzumab deruxtecan) for people with HER2-low metastatic breast cancer (MBC) to be subsidised on the ...
11 months ago101Views
0likes
0Comments
The Lobular Breast Cancer Alliance is conducting a survey of people living with invasive lobular carcinoma and their experiences with surveillance, meaning the monitoring for a local recurrence or dis...
4 months ago32Views
1like
1Comment
The LAA is working to improve the availability of public lymphoedema treatment practitioners and treatment centers
And also to get treatment and garment costs included in Medicare. BCNA is a partn...
10 years ago1View
0likes
3Comments
A brilliant article about the not always talked about dreaded lymphedema and the importance of finding a good lymphedema therapist. This really resonated with me as I am suffering a recent flare-up a...
9 years ago21Views
0likes
3Comments
Email from ABC Global Alliance Dear All,
The
COVID-19 is creating a status of unprecedent uncertainty also by disrupting the
continuity and quality of care in other disease areas such as ca...
5 years ago171Views
0likes
1Comment